Argos Therapeutics, Inc. announced earnings results for the fourth quarter and full year ended December 31, 2017. For quarter, the company reported revenue of $1,670,949 against $163,640 a year ago. Operating loss was $2,343,975 against $15,706,812 a year ago. Net loss was $1,892,871 or $0.38 per basic and diluted share against $15,354,836 or $7.45 per basic and diluted share a year ago. For year, the company reported revenue was $1,899,398 against $945,468 a year ago. Operating loss was $62,458,557 against $52,306,183 a year ago. Net loss was $40,577,110 or $13.45 per basic and diluted share against $53,028,110 or $33.14 per basic and diluted share a year ago.